HLB Pharmaceutical Co

HLB Pharmaceutical Co EBIT per Share

The EBIT per Share of HLB Pharmaceutical Co (047920.KQ) as of Oct 19, 2026 is 142.42 KRW. In the previous year, EBIT per Share was 44.76 KRW — a change of 218.16% (higher).

EBIT per Share

142.42KRW

YoY

218.16%

Last updated:

EBIT per Share of HLB Pharmaceutical Co is 2025 142.42 KRW. EBIT per Share of HLB Pharmaceutical Co was 2024 44.76 KRW. It decreases by 218.16% higher compared to the previous year.

The HLB Pharmaceutical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2017
-242.55 KRW
Jan 1, 2018
-390.75 KRW
Jan 1, 2019
72.37 KRW
Jan 1, 2021
18.63 KRW
Jan 1, 2022
-230.24 KRW
Jan 1, 2023
-179.63 KRW
Jan 1, 2024
44.76 KRW
Jan 1, 2025
142.42 KRW
The HLB Pharmaceutical Co EBIT per Share history
YEAREBIT per ShareYoY
142.42KRW+218.16%
44.76KRW-124.92%
-179.63KRW-21.98%
-230.24KRW-1,335.74%
18.63KRW-74.26%
72.37KRW-118.52%
-390.75KRW+61.10%
-242.55KRW-808.12%
34.25KRW-128.38%
-120.71KRW-322.78%
54.18KRW+38.92%
39.00KRW-76.34%
164.86KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HLB Pharmaceutical Co Stock analysis

What does HLB Pharmaceutical Co do? HLB Pharmaceutical Co Ltd, based in Namyangju, South Korea, operates in the Health Care sector, specializing in biotechnology-based pharmaceutical manufacturing. The company, listed on 21 December 2015, employs 230 people and produces a range of products including cimetidine, rabeprazole, and L-carnitine tablets, as well as OTC and ETC drugs like gynobetadine suppositories and commissioned medications. HLB Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HLB Pharmaceutical Co stock

EBIT per Share of HLB Pharmaceutical Co is 142.42 KRW in 2025.

EBIT per Share of HLB Pharmaceutical Co changed from 44.76 KRW to 142.42 KRW, representing a 218.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share HLB Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — HLB Pharmaceutical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — HLB Pharmaceutical Co